Financial comparisons Neurizon Therapeutics Limited

Equities

Delayed Australian S.E. Other stock markets 05:30:01 14/07/2025 am IST			5-day change	1st Jan Change
0.1650 ^AUD	0.00%		+6.45%	-2.94%

10/07	Neurizon Therapeutics Receives US FDA Support to Lift Clinical Hold on ALS Trial	MT
03/07	Elanco Animal Health Enters Into Licensing Agreement With Neurizon for Monepantel	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Revenues (N-1)	Net Margin (N-1)	EBIT Margin (N-1)	ROE (N-1)	ROA (N-1)	Leverage (N-1)
ELI LILLY AND COMPANY	4.5TCr	23.51%	31.78%	84.84%	14.84%	1.88x
JOHNSON & JOHNSON	8.88TCr	15.84%	29.8%	34.23%	13.95%	0.36x
ABBVIE INC.	5.63TCr	7.59%	41.43%	263.08%	13.34%	2.56x
NOVO NORDISK A/S	4.03TCr	34.78%	44.19%	80.78%	25.88%	0.52x
ROCHE HOLDING AG	6.68TCr	13.68%	34.42%	43.45%	15.69%	0.74x
NOVARTIS AG	5.03TCr	23.73%	38.74%	34.74%	15.58%	0.85x
ASTRAZENECA PLC	5.41TCr	13.01%	31.31%	32.11%	12.51%	1.47x
MERCK & CO., INC.	6.42TCr	26.68%	36.46%	46.35%	17.38%	0.86x
AMGEN INC.	3.34TCr	12.24%	44.96%	177.29%	11.36%	2.33x
PFIZER, INC.	6.36TCr	12.62%	34.24%	19.99%	8.05%	1.52x
GILEAD SCIENCES, INC.	2.88TCr	1.67%	29.63%	27.6%	9.57%	1.48x
VERTEX PHARMACEUTICALS INCORPORATED	1.1TCr	-4.86%	6.31%	0.65%	0.49%	-6.77x
SANOFI	4.25TCr	13.98%	27.61%	11.75%	4.43%	0.68x
BRISTOL-MYERS SQUIBB COMPANY	4.83TCr	-18.53%	10.77%	10.23%	-9.53%	6.49x
GSK PLC	3.93TCr	8.21%	29.16%	48.09%	10.97%	1.22x
CHUGAI PHARMACEUTICAL CO., LTD.	744.57Cr	33.09%	46.3%	22%	18.71%	-1.74x
JIANGSU HENGRUI MEDICINE CO., LTD.	383.4Cr	22.64%	26.77%	14.73%	13.49%	-2.98x
TAKEDA PHARMACEUTICAL COMPANY LIMITED	3.06TCr	2.36%	7.48%	1.5%	1.19%	3.6x
Average	4.3TCr	13.46%	30.63%	52.97%	10.99%	0.84x
Weighted average by Cap.	5.05TCr	16.62%	33.31%	72.46%	13.4%	1.10x